Avacta Group (AVCT)

 

Latest News

Director/PDMR Shareholding

RNS Number: 3868V Avacta Group PLC 30 January 2017 30 January 2017 Avacta Group plc ("Avacta" or "the Group" or "the Company") Director/PDMR Shareholding Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, announces the following changes to the equity incentives of its Chief Executive Officer, Alastair Sm...

Result of Annual General Meeting

RNS Number: 7412U Avacta Group PLC 20 January 2017 20 January 2017 Avacta Group plc ("Avacta" or "the Group" or "the Company") Result of Annual General Meeting Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, announces that at the Annual General Meeting held earlier today, all resolutions were duly pas...

Avacta sees substantial progress

Avacta Group has made substantial progress in the past year in demonstrating the performance and differentiation of its ...

Trading Update

RNS Number: 6699U Avacta Group PLC 20 January 2017 20 January 2017 Avacta Group plc ("Avacta" or "the Group" or "the Company") AGM business update and notice of results Substantial progress in therapeutic programme Multiple third party technology evaluations ongoing Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and resea...

All News

DateHeadlineSource
30-01-17Director/PDMR ShareholdingRNS
20-01-17Result of Annual General MeetingRNS
20-01-17Avacta sees substantial progress StockMarketWire
20-01-17Trading UpdateRNS
11-01-17Avacta CEO to present at London forum StockMarketWire
11-01-17Presenting at London Growth and Innovation ForumRNS
06-01-17Avacta Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 2017StockMarketWire
05-01-17Director Dealing and Issue of EquityRNS
20-12-16Director/PDMR ShareholdingRNS
16-12-16Holding(s) in CompanyRNS
01-12-16Notice of AGM, Accounts and Directorate ChangeRNS
23-11-16Avacta to present positive Affimer dataStockMarketWire
23-11-16Technical Update: Affinity SeparationRNS
07-11-16Cancer expert joins Avacta scientific advisory board StockMarketWire
07-11-16Cancer Expert joins Scientific Advisory BoardRNS
02-11-16Avacta cell therapy research collaboration in USStockMarketWire
02-11-16CAR-T Cell Therapy Research Collaboration in USRNS
01-11-16Avacta to present positive Affimer resultsStockMarketWire
01-11-16Results from first Affimer pre-clinical studiesRNS
21-10-16Director Deals - Avacta Group PLC (AVCT)StockMarketWire
21-10-16Director's DealingRNS
17-10-16Hardman Research: Great strides to strategic goalsRNS
17-10-16Broker Forecast - finnCap issues a broker note on Avacta Group PLCStockMarketWire
17-10-16Prelim Results for the Year Ended 31 July 2016RNS
04-10-16Issue of EquityRNS
26-09-16Notice of ResultsRNS
22-09-16Positive results from first preclinical studiesRNS
12-09-16Change of AdviserRNS
31-08-16Avacta changes registered office StockMarketWire
31-08-16Change of Registered OfficeRNS
16-08-16Avacta opens new facilities in Cambridge and WetherbyStockMarketWire
16-08-16New Facilities in Cambridge and WetherbyRNS
10-08-16Avacta gets grant funding for new diagnostic testsStockMarketWire
10-08-16Grant FundingRNS
03-08-16Avacta granted key Affimer patents in Europe and US StockMarketWire
03-08-16Key Affimer patents to be granted in Europe and USRNS
01-08-163 stocks set to soar after today’s news flow?Motley Fool
01-08-16Trading StatementRNS
19-07-16Holding(s) in CompanyRNS
19-07-16Hardman report: New Affimer opportunitiesRNS

RSS feeds

  • Editorial news feed for LSE:AVCT Editorial
  • Regulatory news feed for LSE:AVCT Regulatory